Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents

Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors Discovery of adamantane based highly potent HDAC inhibitors Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors